Eloctate Antihemophilic factor (Recombinant)Fc fusion protein
Condition : New
0
From UAE
To United States
in 5-10 days
Description
How It Works
Eloctate works by replacing the missing or deficient factor VIII in patients with hemophilia A. Factor VIII is crucial for the formation of blood clots, and its absence or deficiency can lead to prolonged bleeding. Eloctate provides the necessary factor VIII, helping to restore the blood’s ability to clot and prevent bleeding episodes.Side Effects
- Headache
- Nausea
- Joint pain
- Injection site reactions (such as redness, swelling, or itching)
- Increased liver enzymes
Indications
- Prophylaxis to prevent bleeding episodes in patients with hemophilia A
- On-demand treatment of bleeding episodes
- Perioperative management of bleeding in patients with hemophilia A
Contraindications
- Hypersensitivity to any component of Eloctate
- Known allergic reactions to hamster protein
Price Comparison in Different Countries
Country | Price (USD) | Reference |
---|---|---|
United States | $1,500.00 | GoodRx |
United Kingdom | ?1,200.00 | NHS UK |
Australia | $2,000.00 AUD | Pharmaceutical Benefits Scheme Australia |
Canada | $1,800.00 CAD | MedBroadcast Canada |
Top 5 Global Brands
- Baxter International
- Biogen
- Pfizer
- Roche
- Sanofi